QQQ $ 624.58 $ 6.16 (1 %)
DIA $ 473.74 $ 2.86 (0.61 %)
SPY $ 678.92 $ 3.91 (0.58 %)
TLT $ 88.97 $ -0.54 (-0.6 %)
GLD $ 366.35 $ -0.10 (-0.03 %)
$ 12.49
-- x --
-- x --
-- - --
$ 5.90 - $ 12.51
0
na
798.9M
$ 1.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 12-10-2024 10-31-2024 10-Q
2 09-09-2024 07-31-2024 10-Q
3 07-02-2024 04-30-2024 10-K
4 04-24-2024 01-31-2024 10-Q
5 12-07-2023 10-31-2023 10-Q
6 09-07-2023 07-31-2023 10-Q
7 06-21-2023 04-30-2023 10-K
8 03-13-2023 01-31-2023 10-Q
9 12-06-2022 10-31-2022 10-Q
10 09-06-2022 07-31-2022 10-Q
11 06-29-2022 04-30-2022 10-K
12 03-08-2022 01-31-2022 10-Q
13 12-07-2021 10-31-2021 10-Q
14 09-08-2021 07-31-2021 10-Q
15 06-29-2021 04-30-2021 10-K
16 03-08-2021 01-31-2021 10-Q
17 12-02-2020 10-31-2020 10-Q
18 09-01-2020 07-31-2020 10-Q
19 06-30-2020 04-30-2020 10-K
20 03-10-2020 01-31-2020 10-Q
21 12-09-2019 10-31-2019 10-Q
22 09-05-2019 07-31-2019 10-Q
23 06-27-2019 04-30-2019 10-K
24 03-11-2019 01-31-2019 10-Q
25 12-10-2018 10-31-2018 10-Q
26 09-10-2018 07-31-2018 10-Q
27 07-16-2018 04-30-2018 10-K
28 03-12-2018 01-31-2018 10-Q
29 12-11-2017 10-31-2017 10-Q
30 09-11-2017 07-31-2017 10-Q
31 07-14-2017 04-30-2017 10-K
32 03-13-2017 01-31-2017 10-Q
33 12-12-2016 10-31-2016 10-Q
34 09-08-2016 07-31-2016 10-Q
35 07-14-2016 04-30-2016 10-K
36 03-09-2016 01-31-2016 10-Q
37 12-10-2015 10-31-2015 10-Q
38 09-09-2015 07-31-2015 10-Q
39 07-14-2015 04-30-2015 10-K
40 03-12-2015 01-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(...

Core News & Articles

RBC Capital analyst Sean Dodge downgrades Avid Bioservices (NASDAQ:CDMO) from Outperform to Sector Perform and raises the pr...

Core News & Articles

William Blair analyst Max Smock reiterates Avid Bioservices (NASDAQ:CDMO) with a Market Perform.

Core News & Articles

The per share purchase price represents a 13.8% premium to Avid's closing share price of $10.98 on November 6, 2024, the la...

Core News & Articles

RBC Capital analyst Sean Dodge maintains Avid Bioservices (NASDAQ:CDMO) with a Outperform and raises the price target from $...

Core News & Articles

Stephens & Co. analyst Jacob Johnson reiterates Avid Bioservices (NASDAQ:CDMO) with a Overweight and maintains $12 price...

Core News & Articles

William Blair analyst Max Smock reiterates Avid Bioservices (NASDAQ:CDMO) with a Market Perform.

Core News & Articles

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0....

 why-avid-bioservices-stock-is-moving-higher-wednesday

Avid reported fourth quarter financial results on Tuesday after the market closed. The company reported a loss of $1.94 per sha...

Core News & Articles

RBC Capital analyst Sean Dodge reiterates Avid Bioservices (NASDAQ:CDMO) with a Outperform and maintains $8 price target.

Core News & Articles

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(1.94) per share which missed the analyst consensus estimate of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION